Herbal medicine, randomised controlled trials and global core competencies

South African Medical Journal

Volumn 102, Issue 12, 2012, Pages 912-913

  Siegfried, N ^a,b   Hughes, G ^c,d  

^a UNIVERSITY OF THE WESTERN CAPE   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PELARGONIUM SIDOIDES EXTRACT;

AFRICAN MEDICINE; ARTICLE; DIAGNOSTIC PROCEDURE; DRUG EFFICACY; ETHNOBOTANY; GOOD MANUFACTURING PRACTICE; HERBAL MEDICINE; HUMAN; PATENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESEARCH ETHICS; SYSTEMATIC REVIEW; TRADITIONAL HEALER;

HERBAL MEDICINE; HUMANS; PHYTOTHERAPY; PLANTS, MEDICINAL; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOUTH AFRICA;

EID: 84870678203     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: 10.7196/SAMJ.6392     Document Type: Article

References (17)

1. Van Niekerk J. Traditional healers formalised? S Afr Med J 2012;102(3):105-106.
2. Schulz KF. Unbiased research and the human spirit: the challenges of randomized controlled trials. CMAJ 1995;153(6):783-786.
3. Nxumalo N, Alaba O, Harris B, Chersich M, Goudge J. Utilization of traditional healers in South Africa and costs to patients: findings from a national household survey. J Public Health Policy. 2011;32 Suppl 1:S124-136.
4. Peltzer K. Utilization and practice of traditional/complementary/alternative medicine (TM/CAM) in South Africa. Afr J Tradit Complement Altern Med 2009;6(2):175-185.
5. Peltzer K. Traditional health practitioners in South Africa. Lancet. 2009;374(9694):956-957.
6. Egger M, Davey-Smith G, O'Rourke K. Rationale, Potentials, and Promise of Systematic Reviews. In: Egger M, Davey-Smith G, Altman DG, eds. Systematic Reviews in Health Care: Meta-analysis in Context. 2nd ed. London: BMJ Publishing Group; 2001:3-19.
7. Timmer A, Gunther J, Rucker G, Motschall E, Antes G, Kern WV. Pelargonium sidoides extract for acute respiratory tract infections. Cochrane Database Syst Rev. 2008(3):CD006323.
8. Willcox ML, Graz B, Falquet J, Sidibe O, Forster M, Diallo D. Argemone mexicana decoction for the treatment of uncomplicated falciparum malaria. Trans R Soc Trop Med Hyg 2007;101(12):1190-1198.
9. Graz B, Willcox ML, Diakite C, et al. Argemone mexicana decoction versus artesunate-amodiaquine for the management of malaria in Mali: policy and public-health implications. Trans R Soc Trop Med Hyg 2010;104(1):33-41.
10. Wambebe C, Khamofu H, Momoh JA, et al. Double-blind, placebo-controlled, randomised cross-over clinical trial of NIPRISAN in patients with sickle cell disorder. Phytomedicine 2001;8(4):252-261.
11. Whelan AM, Jurgens TM, Szeto V. Case report. Efficacy of Hoodia for weight loss: is there evidence to support the efficacy claims? J Clin Pharm Ther 2010;35(5):609-612.
12. Oniyangi O, Cohall DH. Phytomedicines (medicines derived from plants) for sickle cell disease. Cochrane Database Syst Rev. (10):CD004448.
13. Johnson Q, Syce J, Nell H, Rudeen K, Folk WR. A randomized, double-blind, placebo-controlled trial of Lessertia frutescens in healthy adults. PLoS Clinical Trials 2007;2(4):e16.
14. Willcox M, Siegfried N, Johnson Q. Capacity for clinical research on herbal medicine in Africa. Journal Alt Complement Med 2012;18(6):622-688.
15. Siegfried N, Volmink J, Dhansay A. Does South Africa need a national clinical trials support unit? S Afr Med J 2010;100(8):521-524.
16. OECD Global Science Forum. Facilitating International Cooperation in Non-Commercial Clinical Trials, October 2011. http://www.oecd.org/science/scienceandtechnologypolicy/49344626.pdf (accessed 4 June 2012).
17. Siegfried N, Steinhausen K, Ren J, Cazap E, Melien O. Training, infrastructure and patient involvement, OECD GSF Working Group. Global core competencies for clinical trials. The Lancet 2012; in press.